How to Learn More
Clinical Trial Inquiries
Clinical trials are a critical part of the approval process for new vaccines and therapeutics. People who participate in clinical trials play an important role in characterizing how a potential new vaccine or therapy may be able to prevent or treat a particular disease or condition.
For more information about the clinical trials investigating Genocea novel immunotherapies or vaccines, please visit www.genocea.com or the NIH website www.clinicaltrials.gov , a comprehensive resource for all ongoing clinical trials from different organizations and institutions.
For more information about the about the clinical trial process, please visit the National Institutes of Health (NIH) frequently asked question website that addresses many of the most common questions about clinical trials.
If you are interested in participating in a specific clinical study, you can talk to your health care professional or email firstname.lastname@example.org for more information.
For physicians interested in a clinical trial at Genocea please contact email@example.com.
About Genital Herpes
To learn more about genital herpes, please visit Disease Focus Genital Herpes.
To learn more about GEN-003, please visit GEN-003 for Genital Herpes. Right now GEN-003 is still an investigational product and not available commercially. It has not been approved for use by the US Food and Drug Administration or any similar foreign regulatory authority. We do not know if or when GEN-003 will be available in the US or in other countries. New treatments or vaccines for diseases such as genital herpes are not available by prescription until they are approved by regulatory authorities such as the FDA.
For additional information about our investigational vaccines, please visit our Clinical Inquiries page and we will respond to your inquiry in a timely manner.